Arcturus Therapeutics (ARCT) PT Lowered to $20 at Wells Fargo
Tweet
Share
E-mailGet Alerts ARCT Hot Sheet
Price: $16.96 +4.50%
Rating Summary:
13 Buy, 5 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Rating Summary:
13 Buy, 5 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Join SI Premium – FREE
Wells Fargo analyst Yanan Zhu lowered the price target on Arcturus Therapeutics (NASDAQ: ARCT) to $20.00 (from $42.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- ONEOK Inc (OKE) PT Raised to $104 at Truist Securities
- Medtronic, Inc. (MDT) PT Raised to $115 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
